You may have seen this word on certain products or specialized websites: cosmeceutical. Between classic cosmetics and medicine, there would be a third category, more effective, more scientific, and more serious.
The reality is more nuanced — and understanding the difference changes how you choose your products.
In European law, there is no "cosmeceutical" category. But the distinction remains real in terms of efficacy.
What European law says about cosmetics
In Europe, a cosmetic product is defined by Regulation (EC) No 1223/2009 as any substance intended to be placed in contact with the external parts of the human body with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, or keeping them in good condition. The legal definition explicitly excludes any action on deep biological functions.
A medicine, on the other hand, is defined by its ability to prevent or treat a disease, or to modify a physiological function. It is subject to a marketing authorization (MA) involving rigorous clinical trials.
Between the two, there is no intermediate legal status in Europe. The term "cosmeceutical" has no regulatory existence in European territory. A product is either a cosmetic or a medicine. It cannot be both.
Why the term "cosmeceutical" still exists
The term was popularized by dermatologist Albert Kligman in the 1980s to refer to cosmetic products formulated with active ingredients at concentrations sufficient to produce a measurable biological effect on the skin — without falling under the category of medicine. The idea is sound. European legal framework simply has not integrated it.
In the United States, the Food and Drug Administration (FDA) also does not officially recognize this category, but regulations there are less strict on cosmetic claims, which explains why the term is more widespread in American products.
The real difference: active ingredient concentration and level of proof
What the term "cosmeceutical" seeks to express is a distinction in the quality of formulation. A standard cosmetic may contain an active ingredient at an insufficient dose to produce a measurable effect — this is the principle of "fairy dusting." A rigorously formulated product contains its active ingredients at concentrations validated by scientific literature.
This difference is what truly matters. Not the "cosmeceutical" label — which can be affixed by any brand without regulatory control — but the actual quality of the formulation: position of active ingredients in the INCI list, plausible concentrations, formula stability, and clinical evidence level of the active ingredients used.
Parapharmacy: a positioning between the two
Parapharmacy occupies a particular position in this landscape. It distributes cosmetic products, but selected according to stricter criteria than mass retail: documented active ingredients, brands that have invested in clinical research, formulations validated by health professionals.
Major parapharmacy brands (La Roche-Posay, Avène, Bioderma, CeraVe, SVR) publish clinical studies on their formulations, work with dermatologists, and invest in the validation of their active ingredients. This is not an absolute guarantee of efficacy for every product, but it represents a formally higher level of seriousness than mass-market cosmetics.
What this means concretely for choosing
Beware of products that display "cosmeceutical" as their main argument — the term is not controlled and can be used by anyone. What matters is transparency regarding concentrations, the presence of independent clinical studies, and consistency between promises and actual formulation.
A well-formulated cosmetic product, with active ingredients at effective doses and a stable base, produces measurable results on the skin. A product labeled "cosmeceutical" with "fairy dusting" does nothing — legally or otherwise.
The Paradermia Approach
At Paradermia, our pharmacist selects products based on their actual formulation: active ingredients at effective doses, available clinical studies, and consistency between claims and INCI composition. We don't stop at labels — neither "cosmeceutical," nor "clinically tested," nor "dermatologist approved" — but at what the product truly contains.
Frequently Asked Questions
Are Paradermia products cosmeceuticals?
They are cosmetics selected according to pharmaceutical rigor criteria: verified formulation, active ingredients at documented doses, relevance to the profiles for which they are recommended. Since the term "cosmeceutical" has no regulatory value in Europe, we prefer to speak of cosmetics with validated formulations.
Are parapharmacy products more effective than mass-market products?
Generally, yes — not because they are "cosmeceuticals," but because parapharmacy brands invest more in formulation and clinical studies. This is not an absolute rule: a well-formulated mass-market product can outperform a poorly dosed parapharmacy product. Formulation always takes precedence.
Sources
- European Parliament and Council. (2009). Regulation (EC) No 1223/2009 on cosmetic products, Article 2. Official Journal of the European Union, L 342/59.
- Kligman A. (2005). The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD. Dermatologic Surgery, 31(7 Pt 2):890-891. doi:10.1111/j.1524-4725.2005.31734.x
- Dureja H, Kaushik D, Gupta M, et al. (2005). Cosmeceuticals: an emerging concept. Indian Journal of Pharmacology, 37(3):155-159. doi:10.4103/0253-7613.16211
- U.S. Food and Drug Administration. (2018). "Cosmeceutical" — Cosmetics Labeling Claims. fda.gov/cosmetics/cosmetics-labeling-claims/cosmeceutical
